Autophagy is an important pro-survival mechanism and closely related to apoptosis. The aim of this study was to investigate whether hydroxychloroquine (HCQ) blocks autophagy and promotes apoptosis of the prostate after castration. Methods: Thirty-six male SD rats were randomly divided into 3 groups (n = 12): control group (sham operation), castration group, and HCQ group (castrated and treated with HCQ). On day 7, all mice were executed and prostates were isolated. The morphological changes of prostates were observed by light microscope, and the ultrastructure changes were observed under scanning electron microscope (SEM). The protein expression of Beclin-l, P62, caspase-3, Bcl-2, and Bax was assessed by immunohistochemical analyses. The mRNA expression of microtubule-associated protein light chain 3 (LC3) and autophagy-related gene 5 (Atg5) was detected by RT-PCR. Results: Prostates of castration group shrank remarkably and prostates of HCQ group shrank more remarkably than castration group. Cytolysosomes were visible in the prostates of the castration group under SEM. Immunohistochemistry showed that the protein of Beclin-1 increased in the castration group compared to the control group, while decreased in the HCQ group compared to the castration group. While P62 protein moderately dyed in the control group and weakly dyed in the castration group, it strongly dyed in the HCQ group. Caspase-3 and Bax protein were weakly dyed in the control group but moderately dyed in the castration group and strongly dyed in the HCQ group. The expressions of apoptosis suppressor Bcl-2 were reduced in the castration group and further reduced in the HCQ group compared to the castration group. RT-PCR revealed that the mRNA of LC3 and Atg5 in the castration group increased compared to the control group, while decreased after treated with HCQ. Conclusion: Autophagy increased after castrated in prostates, while decreased after treated with HCQ; all these indicated that HCQ blocked autophagy and then promoted prostate apoptosis of castrated mice.

1.
Blessing
AM
,
Rajapakshe
K
,
Reddy Bollu
L
,
Shi
Y
,
White
MA
,
Pham
AH
, et al.
Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression
.
Autophagy
.
2017
;
13
(
3
):
506
21
.
2.
Copeland
BT
,
Du
J
,
Pal
SK
,
Jones
JO
.
Factors that influence the androgen receptor cistrome in benign and malignant prostate cells
.
Mol Oncol
.
2019
:
13
(
12
):
2616
32
.
3.
Taylor
RA
,
Watt
MJ
.
Unsuspected protumorigenic signaling role for the oncometabolite GABA in advanced prostate cancer
.
Cancer Res
.
2019
;
79
(
18
):
4580
1
.
4.
Jia
J
,
Zhang
HB
,
Shi
Q
,
Yang
C
,
Ma
JB
,
Jin
B
, et al.
KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy
.
Theranostics
.
2019
;
9
(
19
):
5464
77
.
5.
Hansen
AR
,
Tannock
IF
,
Templeton
A
,
Chen
E
,
Evans
A
,
Knox
J
, et al.
Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): phase II trial of high dose pantoprazole (autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer (mCRPC)
.
Oncologist
.
2019
;
24
(
9
):
1188
94
.
6.
Hsieh
C-L
,
Huang
H-S
,
Chen
K-C
,
Saka
T
,
Chiang
C-Y
,
Chung
LWK
, et al.
A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway
.
Mol Cancer Ther
.
2020
;
19
(
1
):
101
11
.
7.
Qu
X
,
Zou
Z
,
Sun
Q
,
Luby-Phelps
K
,
Cheng
P
,
Hogan
RN
, et al.
Autophagy gene-dependent clearance of apoptotic cells during embryonic development
.
Cell
.
2007
;
128
(
5
):
931
46
.
8.
Andrejeva
G
,
Gowan
S
,
Lin
G
,
Wong Te Fong
AL
,
Shamsaei
E
,
Parkes
HG
, et al.
De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy
.
Autophagy
.
2019
;
16
(
6
):
1044
60
.
9.
Geng
J
,
Klionsky
DJ
.
The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. “Protein modifications: beyond the usual suspects” review series
.
EMBO Rep
.
2008
;
9
(
9
):
859
64
.
10.
Udensi
UK
,
Tchounwou
PB
.
Oxidative stress in prostate hyperplasia and carcinogenesis
.
J Exp Clin Cancer Res
.
2016
;
35
(
1
):
139
.
11.
Zhao
R
,
Bei
X
,
Yang
B
,
Wang
X
,
Jiang
C
,
Shi
F
, et al.
Endothelial cells promote metastasis of prostate cancer by enhancing autophagy
.
J Exp Clin Cancer Res
.
2018
;
37
(
1
):
221
.
12.
Solomon
VR
,
Lee
H
.
Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies
.
Eur J Pharmacol
.
2009
;
625
(
1–3
):
220
33
.
13.
Kumano
M
,
Furukawa
J
,
Shiota
M
,
Zardan
A
,
Zhang
F
,
Beraldi
E
, et al.
Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress in prostate cancer
.
Mol Cancer Ther
.
2012
;
11
(
8
):
1661
71
.
14.
Mizushima
N
.
Methods for monitoring autophagy
.
Int J Biochem Cell Biol
.
2004
;
36
(
12
):
2491
502
.
15.
Yang
YP
,
Hu
LF
,
Zheng
HF
,
Mao
CJ
,
Hu
WD
,
Xiong
KP
, et al.
Application and interpretation of current autophagy inhibitors and activators
.
Acta Pharmacol Sin
.
2013
;
34
(
5
):
625
35
.
16.
Karasic
TB
,
O’Hara
MH
,
Loaiza-Bonilla
A
,
Reiss
KA
,
Teitelbaum
UR
,
Borazanci
E
, et al.
Effect of gemcitabine and nab-paclitaxel with or without hydroxychloroquine on patients with advanced pancreatic cancer: a phase 2 randomized clinical trial
.
JAMA Oncol
.
2019
;
5
(
7
):
993
8
.
17.
Klionsky
DJ
,
Emr
SD
.
Autophagy as a regulated pathway of cellular degradation
.
Science
.
2000
;
290
(
5497
):
1717
21
.
18.
Wang
CW
,
Klionsky
DJ
.
The molecular mechanism of autophagy
.
Mol Med
.
2003
;
9
(
3–4
):
65
76
.
19.
Bergamini
E
,
Cavallini
G
,
Donati
A
,
Gori
Z
.
The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically
.
Biomed Pharmacother
.
2003
;
57
(
5–6
):
203
8
.
20.
Fernández
ÁF
,
Sebti
S
,
Wei
Y
,
Zou
Z
,
Shi
M
,
McMillan
KL
, et al.
Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice
.
Nature
.
2018
;
558
(
7708
):
136
40
.
21.
Oltvai
ZN
,
Milliman
CL
,
Korsmeyer
SJ
,
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
.
Cell
.
1993
;
74
(
4
):
609
19
.
22.
Su
D
,
Hu
X
,
Dong
C
,
Ren
J
.
Determination of caspase-3 activity and its inhibition constant by combination of fluorescence correlation spectroscopy with a microwell chip
.
Anal Chem
.
2017
;
89
(
18
):
9788
96
.
23.
Condorelli
G
,
Roncarati
R
,
Ross
J
,
Pisani
A
,
Stassi
G
,
Todaro
M
, et al.
Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function
.
Proc Natl Acad Sci USA
.
2001
;
98
(
17
):
9977
82
.
24.
Sakurai
M
,
Nagata
T
,
Abe
K
,
Horinouchi
T
,
Itoyama
Y
,
Tabayashi
K
.
Survival and death-promoting events after transient spinal cord ischemia in rabbits: induction of Akt and caspase3 in motor neurons
.
J Thorac Cardiovasc Surg
.
2003
;
125
(
2
):
370
7
.
25.
Pu
X
,
Storr
SJ
,
Zhang
Y
,
Rakha
EA
,
Green
AR
,
Ellis
IO
, et al.
Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival
.
Apoptosis
.
2017
;
22
(
3
):
357
68
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.